As of September 2024, Clinuvel Pharmaceuticals has a market cap of $485.22M. This makes Clinuvel Pharmaceuticals the world's 11479th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $520.49M | -1.31% |
2023 | $527.41M | -26.17% |
2022 | $714.31M | -20.36% |
2021 | $896.93M | 21.91% |
2020 | $735.74M | -21.55% |
2019 | $937.81M | 57.18% |
2018 | $596.64M | 121.00% |
2017 | $269.97M | 9.93% |
2016 | $245.58M | 183.27% |
2015 | $86.69M | -37.38% |
2014 | $138.45M | 342.11% |
2013 | $31.32M | -48.09% |
2012 | $60.32M | 17.31% |
2011 | $51.42M | -24.64% |
2010 | $68.23M | -23.33% |
2009 | $89.00M | 12.50% |
2008 | $79.11M | -30.43% |
2007 | $113.72M | -52.41% |
2006 | $238.98M | 122.89% |
2005 | $107.22M | -63.04% |
2004 | $290.13M | 37.31% |
2003 | $211.29M | 415.38% |
2002 | $41.00M | -48.00% |
2001 | $78.84M | - |